Cover storyNPPA Slashes Cancer Drug Prices: ₹696 Becomes ₹73
India’s drug regulator capped mark-ups on 137 cancer drugs, and one brand falls by about 90% from November 9, 2026.
Cover storyIndia’s drug regulator capped mark-ups on 137 cancer drugs, and one brand falls by about 90% from November 9, 2026.

Codexis scales ECO Synthesis to 100g oligonucleotide output and targets GMP facility readiness by end of 2027 for early clinical siRNA supply.

Eros Apothecary recalls honey supplement after FDA lab testing detects undeclared tadalafil, flagging e-commerce supply chain oversight gaps.

Artelo's ART27.13 achieves ~40% weight loss combined with semaglutide in nonclinical model; U.S. patent protection expected through 2041.

Grace Therapeutics pursues dual-source CMO strategy for GTx-104 after FDA CRL flags CMC deficiencies, with NDA resubmission tied to whichever site clears readiness first.
Latest edition
SPONSORED
SPONSORED
SPONSORED
Nov 23
Nov 28From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.

